Skip to main content
    K

    Kimberly-Clark Corporation (KMB)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NASDAQ

    $111.34
    +1.91 (+1.75%)

    Market Cap: $67.15B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Kimberly-Clark Corporation (KMB) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Kimberly-Clark (KMB) is expected to report earnings on Jan 25, 2027. In the quarter ended Sep 30, 2026, Kimberly-Clark reported EPS of $1.70, above the $1.69 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    75%(30/40)
    Avg Surprise
    +4.06%
    Streak
    1 Q

    Upcoming Estimates

    Reports Jan 25, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$1.56
    Range$1.23 - $1.79
    16 analysts
    Revenue Consensus
    $6.79B
    Range$6.45B - $7.18B
    13 analysts
    Reports Apr 26, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$1.77
    Range$1.65 - $1.86
    7 analysts
    EPS Revisions
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$1.83-3.0%
    60d ago$1.83-2.9%
    30d ago$1.83-2.9%
    7d ago$1.82-2.7%
    Current$1.77
    Revenue Consensus
    $8.22B
    Range$8.15B - $8.25B
    5 analysts

    Next Report

    KMB has an expected report date of Jan 25, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 16.1% below the $1.86 reported for the quarter ended Dec 31, 2025.

    KMB Earnings Call

    The latest KMB earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, KMB beat 30, missed 9 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $4.13B, down 0.5% from $4.15B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$1.70$1.69$1.55 - $1.70+0.59%Beat-6.6%14N/ANov 5, 2026$4.13B
    Jun 30, 2026$1.80$2.00$1.93 - $2.10-10.00%Miss-6.2%140 up, 2 downAug 4, 2026$4.19B
    Mar 31, 2026$1.97$1.93$1.89 - $1.98+2.07%Beat+2.1%123 up, 2 downApr 28, 2026$4.16B
    Dec 31, 2025$1.86$1.81$1.77 - $1.86+2.76%Beat+24.0%112 up, 3 downJan 27, 2026$4.08B
    Sep 30, 2025$1.82$1.75$1.69 - $1.85+4.00%Beat-0.5%142 up, 8 downOct 30, 2025$4.15B
    Jun 30, 2025$1.92$1.66$1.47 - $1.80+15.66%Beat-2.0%145 up, 2 downAug 1, 2025$4.16B
    Mar 31, 2025$1.93$1.89$1.86 - $1.93+2.12%Beat-4.0%152 up, 2 downApr 22, 2025$4.05B
    Dec 31, 2024$1.50$1.51$1.44 - $1.61-0.66%Miss-0.7%153 up, 3 downJan 28, 2025$3.28B
    Sep 30, 2024$1.83$1.71$1.65 - $1.75+7.02%Beat+5.2%145 up, 4 downOct 22, 2024$4.14B
    Jun 30, 2024$1.96$1.71$1.65 - $1.75+14.62%Beat+18.8%156 up, 1 downJul 23, 2024$4.23B
    Mar 31, 2024$2.01$1.64$1.58 - $1.78+22.56%Beat+20.4%148 up, 0 downApr 23, 2024$5.15B
    Dec 31, 2023$1.51$1.54$1.48 - $1.59-1.95%Miss-1.9%142 up, 4 downJan 24, 2024$1.69B
    Sep 30, 2023$1.74$1.59$1.55 - $1.69+9.43%Beat+24.3%137 up, 0 downOct 24, 2023$5.13B
    Jun 30, 2023$1.65$1.48$1.41 - $1.55+11.49%Beat+23.1%146 up, 0 downJul 25, 2023$5.13B
    Mar 31, 2023$1.67$1.32$1.01 - $1.46+26.52%Beat+23.7%156 up, 0 downApr 25, 2023$5.20B
    Dec 31, 2022$1.54$1.51$1.48 - $1.53+1.99%Beat+18.5%146 up, 1 downJan 25, 2023$4.96B
    Sep 30, 2022$1.40$1.45$1.31 - $1.55-3.45%Miss-13.6%141 up, 0 downOct 25, 2022$5.05B
    Jun 30, 2022$1.34$1.32$1.17 - $1.46+1.52%Beat-8.8%130 up, 3 downJul 26, 2022$5.06B
    Mar 31, 2022$1.35$1.23$1.11 - $1.33+9.76%Beat-25.0%132 up, 1 downApr 22, 2022$5.09B
    Dec 31, 2021$1.30$1.25$1.15 - $1.32+4.00%Beat-23.1%130 up, 1 downJan 26, 2022$4.96B
    Sep 30, 2021$1.62$1.65$1.56 - $1.80-1.82%Miss-5.8%13N/AOct 25, 2021$5.01B
    Jun 30, 2021$1.47$1.71$1.44 - $1.95-14.04%Miss-33.2%13N/AJul 23, 2021$4.72B
    Mar 31, 2021$1.80$1.92$1.84 - $2.07-6.25%Miss-15.5%12N/AApr 23, 2021$4.74B
    Dec 31, 2020$1.69$1.62$1.48 - $1.68+4.32%Beat-1.2%13N/AJan 25, 2021$4.84B
    Sep 30, 2020$1.72$1.73$1.62 - $1.84-0.58%Miss-6.5%11N/AOct 22, 2020$4.68B
    Jun 30, 2020$2.20$1.77$1.71 - $1.90+24.29%Beat+31.7%11N/AJul 23, 2020$4.61B
    Mar 31, 2020$2.13$1.96$1.78 - $2.27+8.67%Beat+28.3%12N/AApr 22, 2020$5.01B
    Dec 31, 2019$1.71$1.70$1.66 - $1.74+0.59%Beat+6.9%12N/AJan 23, 2020$4.62B
    Sep 30, 2019$1.84$1.79$1.70 - $1.88+2.79%Beat+7.6%14N/AOct 22, 2019$4.64B
    Jun 30, 2019$1.67$1.62$1.56 - $1.67+3.09%Beat+5.0%15N/AJul 23, 2019$4.59B
    Mar 31, 2019$1.66$1.55$1.42 - $1.62+7.10%Beat-2.9%15N/AApr 22, 2019$4.60B
    Dec 31, 2018$1.60$1.66$1.60 - $1.73-3.61%Miss+1.9%15N/AJan 23, 2019$4.57B
    Sep 30, 2018$1.71$1.63$1.57 - $1.70+4.91%Beat+6.9%16N/AOct 22, 2018$4.58B
    Jun 30, 2018$1.59$1.57$1.52 - $1.62+1.27%Beat+6.7%15N/AJul 24, 2018$4.60B
    Mar 31, 2018$1.71$1.68$1.61 - $1.84+1.79%Beat+8.9%13N/AApr 23, 2018$4.73B
    Dec 31, 2017$1.57$1.54$1.53 - $1.57+1.95%Beat+8.3%13N/AJan 23, 2018$4.60B
    Sep 30, 2017$1.60$1.54$1.51 - $1.58+3.90%Beat+5.3%13N/AOct 23, 2017$4.67B
    Jun 30, 2017$1.49$1.49$1.47 - $1.530.00%In line-2.6%12N/AJul 25, 2017$4.58B
    Mar 31, 2017$1.57$1.55N/A+1.29%Beat+2.6%N/AN/AApr 24, 2017$4.50B
    Dec 31, 2016$1.45$1.41N/A+2.84%Beat+2.1%N/AN/AJan 24, 2017$4.63B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $7.53, up 3.2% from the year before. It was $6.03 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$7.53+3.2%
    Dec 31, 2024$7.30+11.1%
    Dec 31, 2023$6.57+16.7%
    Dec 31, 2022$5.63-9.0%
    Dec 31, 2021$6.19-20.0%
    Dec 31, 2020$7.74+12.5%
    Dec 31, 2019$6.88+4.1%
    Dec 31, 2018$6.61+6.1%
    Dec 31, 2017$6.23+3.3%
    Dec 31, 2016$6.03N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,500 words across 12 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20268,50212
    2026Q2Jun 30, 20265,48014
    2026Q1Mar 31, 20264,68313
    2025Q4Dec 31, 20256,59313
    2025Q3Sep 30, 20254,74111
    2025Q2Jun 30, 20253,8089
    2025Q1Mar 31, 20257,20011
    2024Q4Dec 31, 20244,93712

    2026Q3 Earnings Call

    Opening remarks

    Chris Jakubik Vice President, Investor Relations Thank you, and good morning, everyone. I would like to remind everyone that during our comments today, we will make some forward-looking statements that are based on how we see things today. Actual results may differ due to risks and uncertainties, and these are discussed in our earnings release and our filings with the SEC. We will also discuss some non-GAAP financial measures during these remarks. These non-GAAP financial measures should not be considered a replacement for and should be read together with GAAP results. You can find the GAAP-to-non-GAAP reconciliations within our earnings release and the supplemental materials posted at investor.kimberly-clark.com. With that, I'll turn it over to Mike for a few opening comments.

    Mike Hsu CEO All right, thank you, Chris, and thank you, everyone, for joining us. This week marks a new chapter for Kimberly-Clark. We officially completed our acquisition of Kenvue, a defining moment in our 154-year history. We're delighted to welcome the talented Kenvue team. The closure of this transaction marks a major milestone in our Powering Care transformation, a year of rigorous integration planning, and the starting point for an exciting future defined by extraordinary care. We have created a portfolio and set of capabilities uniquely positioned at the intersection of fast-moving consumer goods and healthcare. Our companies share a rich heritage. We've pioneered entire categories, providing everyday essentials that serve billions of people around the world. Consumers have been loyal to our brands for generations because they trust us to provide better care for them and their loved ones. We form deep, lifelong bonds with consumers and translate that intimate relationship into significant lifetime value. Now, we have a generational opportunity to do even more. Everyday health is becoming more personal, more proactive, and more essential. With the addition of the Kenvue brands, we will be there for more people, in more places, and across more everyday health needs. That is the aspiration that guides our new company: better care in more hands to enable smarter health. From baby care to women's health to active aging, consumers require and deserve a higher standard of care, and we will meet that moment with exceptional science-backed innovation and best-in-class execution that continues to raise the standard. We're energized, and we're ready. We've worked to strengthen our base business, enhance our capabilities, and build our combined team. Now, our team is heads-down focused on execution. Near term, we will enhance performance, efficiency, and effectiveness by applying our proven operating model. We will reinvest in our brands to ensure we are delivering superior brand propositions across the value spectrum. Medium term, we will benefit from category and geographic expansion, and longer term, we will capture secular growth tailwinds.

    Frequently Asked Questions About KMB

    When is Kimberly-Clark's next earnings date?

    Kimberly-Clark's next earnings report is expected for Jan 25, 2027.

    Did KMB beat earnings estimates last quarter?

    Yes. Kimberly-Clark reported EPS of $1.70 for the quarter ended Sep 30, 2026, above the $1.69 estimate, a 0.59% surprise.

    What EPS do analysts expect from KMB next quarter?

    The consensus EPS estimate for Kimberly-Clark for the quarter ending Dec 31, 2026 is $1.56 from 16 analysts, with estimates from $1.23 to $1.79.

    How often does KMB beat earnings estimates?

    Kimberly-Clark beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +2.07%.